Basic research immunologist,
Professor, Kennedy Institute of Rheumatology, London, UK.
TNF (Tumor necrosis factor) as a Therapeutic Target by Jan Bondeson, Marc Feldmann, Ravinder N. Maini.
Tumor necrosis factor a (TNF-a) is a well-recognized proinflammatory cytokine, and as such provides an ideal target for anti-inflammatory therapies. Recent developments have shown very exciting results, and in this article, Jan Bondeson, Marc Feldman, and Ravinder N. Maini review the outcome of clinical trials of anti-TNF-a therapies in a range of chronic inflammatory diseases.
Gold medals from the King of Sweden will be placed around the necks of two award winning doctors for their research leading to new treatment in rheumatoid arthritis.
Crafoord Prize 1999 "for identification of TNF blockade as an effective therapeutic principle in rheumatoid arthrits"